Protagonist Therapeutics, Inc. · NASDAQ:PTGX
Giraudo Bryan sold 59,130 Protagonist Therapeutics, Inc. shares (Form 4)
Traded May 7 to May 8, 2026 · Filed May 11, 2026
From May 7 to May 8, 2026, Giraudo Bryan (Director) sold 59,130 Protagonist Therapeutics, Inc. shares at an average US$100.10 for US$5.92M, leaving 12,695 shares. Filed May 11, 2026 (Form 4).
- Sold
- 59,130 shares
- Price
- US$100.10 average (US$100.00 to US$100.14)
- Value
- US$5.92M
- Holding after
- 12,695 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 7, 2026 | Common Stock | Option exercise | 24,000 | US$6.45 | 31,825 | Direct |
| May 7, 2026 | Common Stock | Option exercise | 12,000 | US$6.98 | 43,825 | Direct |
| May 7, 2026 | Common Stock | Sale | 36,000 | US$100.14 | 27,825 | Direct |
| May 7, 2026 | Common Stock | Sale | 12,000 | US$100.07 | 6,000 | Indirect |
| May 8, 2026 | Common Stock | Sale | 6,000 | US$100.00 | 0 | Indirect |
| May 8, 2026 | Common Stock | Sale | 5,130 | US$100.00 | 12,695 | Direct |
Source
Related
- Protagonist Therapeutics, Inc.
- Giraudo Bryan
- Protagonist Therapeutics, Inc. shareholders
- Form 4 · Ali Asif · Oct 2, 2026
- Form 4 · Patel Dinesh V Ph D · Sep 10, 2026
- Form 4 · Patel Dinesh V Ph D · Sep 8, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 13, 2026
- Form 4 · Patel Dinesh V Ph D · Aug 12, 2026